Natural killer cell crossmatch: Functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands

被引:4
|
作者
Han, Mei [1 ]
Fallena, Margarita [1 ]
Guo, Yuhong [1 ]
Stastny, Peter [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA
关键词
NK cells; KIR; cytotoxicity;
D O I
10.1016/j.humimm.2007.02.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Attempts to predict outcome of bone marrow transplantation based on kilter immunoglobulin-like receptor (KIR) and HLA genotyping have yielded discordant results. To better understand the factors involved, we investigated natural kilter (NK) cell function and correlated it with genetics and expression of inhibitory KIR and HLA ligands in 20 normal allogeneic pairs. KIR expression was analyzed by flow cytometry to estimate the percentage of NK cells that could be inhibited by the HLA ligands in each pair combination. NK cytotoxicity against ConA blasts demonstrated a positive correlation between the number of KIR/HLA matches and the predicted number of NK cells that could be inhibited. When 50% or more of the NK cells could be inhibited, cytotoxicity was tower (8%) than when 25% or less of the NK cells expressed KIR with matched HLA (49%) (p < 0.0001). Our data suggest that the interaction between inhibitory KIR and HLA Ligands can be correlated to some extent with NK cell function, but measurement of NK activity may provide the best information for analysis of clinical situations. (C) 2007 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. ALL rights reserved.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 50 条
  • [21] Distribution of killer cell immunoglobulin-like receptors in the Greek population
    Niokou, D
    Spyropoulou-Vlachou, M
    Darlamitsou, A
    Stavropoulos-Giokas, C
    HUMAN IMMUNOLOGY, 2003, 64 (12) : 1167 - 1176
  • [22] Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos
    Contreras, G.
    Alaez, C.
    Murguia, A.
    Garcia, D.
    Flores, H.
    Gorodezky, C.
    TISSUE ANTIGENS, 2007, 69 : 125 - 129
  • [23] Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barre Syndrome
    Blum, Stefan
    Csurhes, Peter
    Reddel, Stephen
    Spies, Judy
    McCombe, Pamela
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 267 (1-2) : 92 - 96
  • [24] Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response
    Parham, P
    IMMUNOLOGY LETTERS, 2004, 92 (1-2) : 11 - 13
  • [25] Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes
    K J Guinan
    R T Cunningham
    A Meenagh
    A Gonzalez
    M M Dring
    B W McGuinness
    D Middleton
    C M Gardiner
    Genes & Immunity, 2010, 11 : 467 - 478
  • [26] Killer-cell immunoglobulin-like receptors (KIR) inhibitory genes and susceptibility to lung cancer
    Larki, Marjan Hematian
    Ghayumi, Seiyed Mohammad Ali
    Barani, Shaghik
    Ghaderi, Abbas
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 380 - 380
  • [27] Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages
    Moffett, Ashley
    Hiby, Susan
    HUMAN REPRODUCTION, 2009, 24 (08) : 2048 - 2049
  • [28] Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes
    Guinan, K. J.
    Cunningham, R. T.
    Meenagh, A.
    Gonzalez, A.
    Dring, M. M.
    McGuinness, B. W.
    Middleton, D.
    Gardiner, C. M.
    GENES AND IMMUNITY, 2010, 11 (06) : 467 - 478
  • [29] Distribution of human killer cell immunoglobulin-like receptors and ligands among blood donors of Catalonia
    Closa, Laia
    Vidal, Francisco
    Herrero, Maria J.
    Caro, Jose L.
    HLA, 2020, 95 (03) : 179 - 188
  • [30] Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors
    Rettman, Pauline
    Blunt, Matthew D.
    Fulton, Rebecca J.
    Vallejo, Andres F.
    Bastidas-Legarda, Leidy Y.
    Espana-Serrano, Laura
    Polak, Marta E.
    Al-Shamkhani, Aymen
    Retiere, Christelle
    Khakoo, Salim, I
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)